COLOPLAST-B (CBHD.DE) Stock Price & Overview
FRA:CBHD • DK0060448595
Current stock price
The current stock price of CBHD.DE is 57.5 EUR. Today CBHD.DE is up by 0.17%. In the past month the price decreased by -10.94%. In the past year, price decreased by -41.7%.
CBHD.DE Key Statistics
- Market Cap
- 12.087B
- P/E
- 22.55
- Fwd P/E
- 15.36
- EPS (TTM)
- 2.55
- Dividend Yield
- 5.38%
CBHD.DE Stock Performance
CBHD.DE Stock Chart
CBHD.DE Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to CBHD.DE. When comparing the yearly performance of all stocks, CBHD.DE is a bad performer in the overall market: 94.38% of all stocks are doing better.
CBHD.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to CBHD.DE. CBHD.DE scores excellent on profitability, but there are some minor concerns on its financial health.
CBHD.DE Earnings
On February 6, 2026 CBHD.DE reported an EPS of 6.2 and a revenue of 7.04B. The company beat EPS expectations (1.6% surprise) and missed revenue expectations (-2.48% surprise).
CBHD.DE Forecast & Estimates
27 analysts have analysed CBHD.DE and the average price target is 77.93 EUR. This implies a price increase of 35.53% is expected in the next year compared to the current price of 57.5.
For the next year, analysts expect an EPS growth of 44.54% and a revenue growth 3.43% for CBHD.DE
CBHD.DE Groups
Sector & Classification
CBHD.DE Financial Highlights
Over the last trailing twelve months CBHD.DE reported a non-GAAP Earnings per Share(EPS) of 2.55. The EPS decreased by -13.16% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 14.3% | ||
| ROA | 8.17% | ||
| ROE | 28.9% | ||
| Debt/Equity | 1.55 |
CBHD.DE Ownership
CBHD.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EL | ESSILORLUXOTTICA | 25.24 | 90.179B | ||
| ESL | ESSILORLUXOTTICA | 25.22 | 89.948B | ||
| 1EL | ESSILORLUXOTTICA | 25.22 | 89.948B | ||
| CVX | CARVOLIX SA | N/A | 190.753M | ||
| GBT | GUERBET | N/A | 112.875M | ||
| ALCJ | CROSSJECT | 5.39 | 103.144M | ||
| PTP | PENTIXAPHARM HOLDING AG | N/A | 44.938M | ||
| IVN | IVISION TECH SPA | N/A | 13.684M |
Related stock screener links
View all stocks in the Health Care Supplies Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About CBHD.DE
Company Profile
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Company Info
IPO: 1983-01-01
COLOPLAST-B
Holtedam 1-3
Humlebaek DK
Employees: 16628
Phone: 4549111111
COLOPLAST-B / CBHD.DE FAQ
What does COLOPLAST-B do?
Coloplast A/S engages in the developing, manufacture, and markets medical products. The company is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for people whose intestinal outlet has been rerouted through the abdominal wall, Continence Care products for people suffering from diseases of and damage to the urinary system, Urology Care products for people suffering from diseases of and damage to the kidneys, the urinary system or the male reproductive system and Wound & Skin Care for the treatment of chronic wounds and skin care products for prevention and treatment. The firm supplies products to hospitals, institutions as well as wholesalers and pharmacies.
Can you provide the latest stock price for COLOPLAST-B?
The current stock price of CBHD.DE is 57.5 EUR. The price increased by 0.17% in the last trading session.
What is the dividend status of COLOPLAST-B?
COLOPLAST-B (CBHD.DE) has a dividend yield of 5.38%. The yearly dividend amount is currently 2.94.
What is the ChartMill technical and fundamental rating of CBHD stock?
CBHD.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the market expecting CBHD stock to perform?
27 analysts have analysed CBHD.DE and the average price target is 77.93 EUR. This implies a price increase of 35.53% is expected in the next year compared to the current price of 57.5.
Can you provide the PE ratio for CBHD stock?
The PE ratio for COLOPLAST-B (CBHD.DE) is 22.55. This is based on the reported non-GAAP earnings per share of 2.55 and the current share price of 57.5 EUR.